Grants and Contributions

The specific objectives of this funding opportunity are to:

• Generate high quality evidence required to optimize the RD diagnosis pathway in Canada;
• Evaluate the health outcomes associated with RDs via the ‘genomics first’ diagnosis pathway compared to the current approach (i.e., genomic testing performed later);
• Determine the economic impact to the health care system for the ‘genomics first’ diagnosis pathway and compare to current diagnostic pathways for RDs;
• Evaluate the socioeconomic and psychological impacts of delays in the diagnosis on patients/families with RDs from a diversity of population groups and communities in Canada using the ‘genomics first’ diagnostic paradigm as a comparator; and,
• Mobilize knowledge to facilitate the implementation, scale and spread of best practices for diagnosing RDs in Canada.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are to:

• Strengthen integration, uptake, deployment and/or scale-up (spread) of evidence-based solutions: Improve existing programs, services, and/or models of care including equitable and inclusive access for diverse groups of people living with cognitive impairment and dementia, and for those that care for them.
• Build capacity: Strengthen implementation science approaches informed by intersectional equity, diversity and inclusion (EDI) considerations among research teams, including early career researchers and knowledge users (i.e., PWLLE, decision makers), in cognitive impairment research.
• Spark interdisciplinary collaborations: Build partnerships and collaborations across sectors and jurisdictions, as appropriate, to co-develop and implement projects to contribute to a sustained and equitable impact beyond the duration of the grant.
• Foster knowledge mobilization and impact: Foster patient-oriented and integrated knowledge mobilization approaches and strategies throughout the research process to inform timely uptake and maximize research relevance and impact.

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

The Lindau Nobel Laureate Meetings help promote science and research by fostering the exchange of knowledge, ideas, and experience between and among Nobel Laureates, scientists of different generations, cultures, and disciplines.